Z_ID_ORG_FINAL_w_name_rgb_NEW2.jpg
Zealand Pharma to Present Data on Glucagon Analog, Dasiglucagon, at the 81st Annual American Diabetes Association Scientific Sessions
June 16, 2021 08:06 ET | Zealand Pharma
Company announcement – No. 39/2021 Zealand Pharma to Present Data on Glucagon Analog, Dasiglucagon, at the 81st Annual American Diabetes Association Scientific Sessions Company to present six...
Logo_Horizontal_Fill_White_Transparent.png
Neurona Therapeutics Presents Clinical Development Plan for Lead Cell Therapy Program at the 16th Conference on Antiepileptic Drug and Device Trials (AEDD TRIALS XVI)
June 16, 2021 08:00 ET | Neurona Therapeutics
Supporting data in preclinical model of drug-resistant epilepsy demonstrate seizure-freedom in 70% of the NRTX-1001 cell therapy treatment group versus 5% in the control group Data demonstrate...
selectaLogo.jpg
Selecta Biosciences to Participate at the Raymond James Human Health Innovation Conference
June 16, 2021 08:00 ET | Selecta Biosciences, Inc.
WATERTOWN, Mass., June 16, 2021 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology company leveraging its clinically validated ImmTOR™ platform to develop tolerogenic...
jounce.png
Jounce Therapeutics to Host Virtual R&D Day on June 23, 2021
June 16, 2021 08:00 ET | Jounce Therapeutics, Inc.
CAMBRIDGE, Mass., June 16, 2021 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and...
pharmather logo.png
PharmaTher To Present At The H.C. Wainwright Psychedelics In Psychiatry And Beyond Virtual Conference
June 16, 2021 08:00 ET | PharmaTher Holdings Ltd.
TORONTO, June 16, 2021 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a clinical-stage psychedelics biotech company, today announced that...
ImpelNeuropharma_RGB.jpg
Impel NeuroPharma to Present at the Raymond James Human Health Innovation Conference
June 16, 2021 08:00 ET | Impel NeuroPharma
SEATTLE, June 16, 2021 (GLOBE NEWSWIRE) -- Impel NeuroPharma, a late-stage biopharmaceutical company focused on the development and commercialization of transformative therapies for patients living...
Axtria Leads Discussion on Pharma’s Advanced Uses of Data Analytics and Artificial Intelligence With 6 Sessions at PMSA 2021 Annual Conference
June 16, 2021 08:00 ET | Axtria Inc.
Berkeley Heights, NJ, June 16, 2021 (GLOBE NEWSWIRE) -- With the elevated importance of data analytics and artificial intelligence (AI)-driven intelligence technology systems for a global life...
Skyharbour Resources Ltd logo
Skyharbour Expands its Current Drill Program at its High Grade Moore Uranium Project, Saskatchewan
June 16, 2021 08:00 ET | Skyharbour Resources Ltd
VANCOUVER, British Columbia, June 16, 2021 (GLOBE NEWSWIRE) -- Skyharbour Resources Ltd. (TSX-V:SYH) (OTCQB:SYHBF) (Frankfurt:SC1P) (the “Company”) is pleased to announce that it is expanding its...
89biologo.png
89bio to Participate in Upcoming Investor Conferences
June 16, 2021 08:00 ET | 89bio, Inc.
SAN FRANCISCO, June 16, 2021 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for...
MIMEDX.png
MIMEDX to Present at the Raymond James 2021 Human Health Innovation Conference
June 16, 2021 08:00 ET | MiMedx Group, Inc
MARIETTA, Ga, June 16, 2021 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), an industry leader in utilizing amniotic tissue as a platform for regenerative...